UMass Amherst Researcher Partners with Chinese Inventor to Develop New Antibiotics

AMHERST, Mass. – Margaret Riley, an evolutionary biologist at the University of Massachusetts Amherst and pioneer in fighting antibiotic-resistant bacteria, announced this week that she is partnering with a Chinese scientist to develop a new drug platform, pheromonicins. The Chinese government is committing $400 million per year to support the newly created Pheromonicin Institute of Beijing. Riley plans to open a sister institute in the Amherst area.

Full story here:

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer